Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Ocoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Digestive System Neoplasms 3 Digestive System Diseases 3 Neoplasms, Glandular and Epithelial 2 Neoplasms 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2 Carcinoma 2 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Stomach Neoplasms 1 Stomach Diseases 1 Sarcoma 1 Rectal Diseases 1 Patient Compliance 1 Pancreatic Neoplasms 1 Pancreatic Diseases 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Gonadal Disorders 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1

Interventions

Exercise 3 Patient Navigation 2 Interviews as Topic 2 regorafenib 1 potassium oxonate 1 beta-Aminoethyl Isothiourea 1 Weights and Measures 1 Videotape Recording 1 Trastuzumab 1 Surveys and Questionnaires 1 Standard of Care 1 Radiation 1 Psychosocial Intervention 1 Oxaliplatin 1 Ocoxin 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Metabolism 1 Leuprolide 1 Lapatinib 1 Goserelin 1 Diet 1 Clodronic Acid 1 Cisplatin 1 Capecitabine 1 Anastrozole 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07210164 2025-10-07

Pre_ERAS

Aristotle University Of Thessaloniki

Phase NA Recruiting

Pain, Postoperative, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡